Search for: "In re: Abbott Laboratories"
Results 81 - 100
of 237
Sorted by Relevance
|
Sort by Date
6 Dec 2010, 6:06 am
" Now, here's the Times: Word quickly reached top executives at Abbott Laboratories that a Baltimore cardiologist, Dr. [read post]
15 Sep 2010, 2:40 am
Highlights this week included: 2nd Circuit denies en banc reconsideration in Cipro case: In re Ciprofloxacin Antitrust Litigation (Patent Docs) (FDA Law Blog) (IPBiz) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
13 Aug 2015, 10:56 am
Forest Laboratories, plaintiffs alleged that defendant manufacturer of brand-name antidepressant Lexapro omitted material efficacy information from the drug label in violation of California’s consumer protection laws. [read post]
1 Oct 2010, 5:25 am
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
12 Sep 2012, 1:46 pm
Supreme Court’s decision in Blonder-Tongue Laboratories, Inc. v. [read post]
5 Jan 2011, 1:34 am
General AUTM’s 2010 Better World Report highlights (PatentlyBIOtech) Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch) US: Patent eligibility and In re Grams (Patent Docs) US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs) US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs) US: Life… [read post]
12 May 2015, 7:35 am
We're not Canadian lawyers, so we gladly outsource Canadian developments to those who are, such as these guys - Mike A. [read post]
16 Aug 2018, 6:38 pm
Antitrust Litig.,551 F.2d 213, 219 (8th Cir. 1997))).(...)We ruled in Abbott Laboratories v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
19 Sep 2014, 3:00 am
The Eighth Circuit found that the dicta In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012) applied to this case. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI decision… [read post]
25 Apr 2013, 5:00 am
We’re bloggers. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over… [read post]
11 Jun 2021, 1:29 pm
Exxon reported that it has already briefed government officials and industry groups, including Texas Governor Greg Abbott, Houston Mayor Sylvester Turner, U.S. [read post]
24 Nov 2010, 8:22 am
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
24 Nov 2010, 8:22 am
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
6 Jul 2007, 4:29 am
Lederle Laboratories, 656 P.2d 293, 297 (Or. 1982). [read post]
13 May 2010, 12:27 pm
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
1 Jul 2010, 5:00 am
Abbott Laboratories, 2004 WL 3245947 (Ind. [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules en banc:… [read post]
